Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Utilization and cost impact of integrating substance abuse treatment and primary care.

Parthasarathy S, Mertens J, Moore C, Weisner C.

Med Care. 2003 Mar;41(3):357-67.

PMID:
12618639
2.

Short-term economic impact of body weight change among patients with type 2 diabetes treated with antidiabetic agents: analysis using claims, laboratory, and medical record data.

Yu AP, Wu EQ, Birnbaum HG, Emani S, Fay M, Pohl G, Wintle M, Yang E, Oglesby A.

Curr Med Res Opin. 2007 Sep;23(9):2157-69. Review.

PMID:
17669232
3.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
4.

Panic disorder: relationship to high medical utilization, unexplained physical symptoms, and medical costs.

Katon W.

J Clin Psychiatry. 1996;57 Suppl 10:11-8; discussion 19-22. Review.

PMID:
8917128
5.
6.

New systems of care for substance use disorders: treatment, finance, and technology under health care reform.

Pating DR, Miller MM, Goplerud E, Martin J, Ziedonis DM.

Psychiatr Clin North Am. 2012 Jun;35(2):327-56. doi: 10.1016/j.psc.2012.03.004. Review.

PMID:
22640759
7.

Using the tidal model of mental health recovery to plan primary health care for women in residential substance abuse recovery.

Young BB.

Issues Ment Health Nurs. 2010 Sep;31(9):569-75. doi: 10.3109/01612840.2010.487969. Review.

PMID:
20701419
8.
9.

Substance abuse and family illness: evidence from health care utilization and cost-offset research.

Lennox RD, Scott-Lennox JA, Holder HD.

J Ment Health Adm. 1992 Spring;19(1):83-95. Review.

PMID:
10171039
10.

Psychosocial treatment for drug abuse. Selected review and recommendations for national health care.

Crits-Christoph P, Siqueland L.

Arch Gen Psychiatry. 1996 Aug;53(8):749-56. Review.

PMID:
8694688
11.

Financing of substance abuse treatment services.

Horgan CM, Merrick EL.

Recent Dev Alcohol. 2001;15:229-52. Review.

PMID:
11449744
12.

Alcohol treatment and health care system reform.

McCrady BS, Langenbucher JW.

Arch Gen Psychiatry. 1996 Aug;53(8):737-46. Review.

PMID:
8694687
13.
14.

The cost-effectiveness of substance abuse treatment.

Barnett PG.

Curr Psychiatry Rep. 1999 Dec;1(2):166-71. Review.

PMID:
11122920
15.

Role of the employee assistance program in helping the troubled worker.

Fitzgerald ST, Hammond SC, Harder KA.

Occup Med. 1989 Apr-Jun;4(2):233-43. Review.

PMID:
2658148
16.

Rx for health care costs: resolving addictions in the general medical setting.

Langenbucher J.

Alcohol Clin Exp Res. 1994 Oct;18(5):1033-6. Review.

PMID:
7847584
17.

Adolescent substance abuse treatment: evidence-based practice in outpatient services.

Kaminer Y.

Curr Psychiatry Rep. 2002 Oct;4(5):397-401. Review.

PMID:
12230969
18.

The heuristic system. Precision and creativity in addiction treatment.

Richards HJ.

J Subst Abuse Treat. 1999 Dec;17(4):269-91. Review.

PMID:
10587930
19.

The costs of drug abuse consequences: a summary of research findings.

French MT, Martin RF.

J Subst Abuse Treat. 1996 Nov-Dec;13(6):453-66. Review.

PMID:
9219142
20.

Addiction: selecting appropriate treatment and using the self-help system.

Zweben JE.

Occup Med. 2002 Jan-Mar;17(1):41-9, iv. Review.

PMID:
11726335

Supplemental Content

Support Center